New study aims to crack the code of deadly skin hardening in kidney patients
NCT ID NCT07511283
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at a rare but serious condition called calciphylaxis, where small blood vessels in the skin harden, often leading to death. Researchers will compare 860 adults with chronic kidney disease—some who have calciphylaxis and some who don't—to find clues about what causes it and how to spot it early. The goal is to gather knowledge that can lead to better prevention and treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CALCIFIC UREMIC ARTERIOLOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Odense University Hospital
RECRUITINGOdense, 5000, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple baking soda pill may protect dialysis Patients' blood vessels
- Can a new graft keep dialysis access working longer?
- Can a common gout pill shield hearts in kidney disease?
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes